Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion type Assertion NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_head.
- NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion description "[We identified individuals with CYP2C9*2 and CYP2C9*3 genotypes (>or=1 variant allele) in the Adenoma Prevention with Celecoxib trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_provenance.
- NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion evidence source_evidence_literature NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_provenance.
- NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion SIO_000772 19233181 NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_provenance.
- NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion wasDerivedFrom befree-20150227 NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_provenance.
- NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_assertion wasGeneratedBy ECO_0000203 NP341860.RAZEqCAqOCeCEwn0a6cIvhMimgIWFbhoNDo_pBe-jjYhc130_provenance.